scispace - formally typeset
H

Hiroyuki Iwahana

Researcher at University of Tokushima

Publications -  64
Citations -  6547

Hiroyuki Iwahana is an academic researcher from University of Tokushima. The author has contributed to research in topics: Gene & Complementary DNA. The author has an hindex of 26, co-authored 64 publications receiving 6409 citations.

Papers
More filters
Journal ArticleDOI

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

TL;DR: The mobility shift analysis of single-stranded DNAs on neutral polyacrylamide gel electrophoresis to detect DNA polymorphisms was developed and SSCPs were found to be allelic variants of true Mendelian traits, and therefore they should be useful genetic markers.
Journal ArticleDOI

Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation.

TL;DR: The results suggest that soluble human ST2 protein in sera may be related to Th2-mediated allergic inflammation inducing acute exacerbation in patients with atopic asthma.
Journal ArticleDOI

Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells

TL;DR: It is demonstrated that the human ST2 gene has two alternative promoters followed by distinct noncoding first exons, which are located more than 8 kb apart and are spliced to the common exon 2 containing the translation initiation site.
Journal ArticleDOI

Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.

TL;DR: Transgenic paracrine expression of IL-10 in situ in the NOD genetic background enhances autoimmune insulitis and diabetes in their onset and severity, ignoring gender difference.
Journal ArticleDOI

Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.

TL;DR: The suppression of diabetes through decreasing IFN-gamma mRNA by the tissue-specific delivery of IL-10 to pancreatic islets with IL- 10-transduced Th1 cells affords the starting basis to develop the gene therapy for autoimmune diabetes.